Federal contractor profile
NOMOCAN PHARMACEUTICALS LLC
UEI H9T8M7ZBYAR8CAGE 7ER28
Active
Overview
- Legal name
- NOMOCAN PHARMACEUTICALS LLC
- Registered location
- NEW YORK, NY, USA
- Primary NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Latest award activity
- Sep 1, 2026
Read company summary
NOMOCAN PHARMACEUTICALS LLC is associated with UEI H9T8M7ZBYAR8 and CAGE 7ER28 in public federal records. AcornBids currently links 1 prime award totaling $499.2K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)). Its public SAM.gov registration lists NEW YORK, NY, USA.
At a glance
Lifetime prime obligations$499.2K
Prime awards1
Awards with future end dates1
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 27, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- NOMOCAN PHARMACEUTICALS LLC
- UEI
- H9T8M7ZBYAR8
- CAGE
- 7ER28
- Registered address
- 310 EAST 67TH STREET, SUITE 1-45, NEW YORK, NY, 10065, USA
- Registration status
- Active
- Primary NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM activation
- Jul 3, 2026
- Initial registration
- Jun 13, 2023
- Entity start
- Mar 4, 2013
- SAM updated
- Jul 3, 2026
- Registration expires
- Jul 1, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N91025C00050PHASE I - DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS SBIR CONTRACTRIPTION. | Department of Health and Human Services | $499.2K | Sep 15, 2025 | Sep 14, 2027 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Jul 3, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Jun 13, 2023 |
| Entity start | Mar 4, 2013 |
| Industry | Reported size status |
|---|---|
| 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| EHSAN SARAFRAZ YAZDI | Government business | Contact method not published | SAM registration | Not available |
| EHSAN SARAFRAZ YAZDI | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
166 awards
80 awards
77 awards
66 awards
59 awards
57 awards
56 awards
42 awards
About NOMOCAN PHARMACEUTICALS LLC
What products and services appear in its federal awards?
Recorded award industries: 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Recorded products and services: AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH.
Examples from recent award records:
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
310 EAST 67TH STREET, SUITE 1-45, NEW YORK, New York 10065, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit